NCR3 and cancer: It might be possible that the tumor may express other NKp30 ligands, such as galactin 3, BAG-6, or others [26]; thus, there exists the possibility that the results in those B7-H6-knocked down cancer cells might be due to compensatory over-expression of other ligands, or other tumor: NK cell interactions.